DK0668874T3 - LHRH-antagonister og mellemprodukter - Google Patents
LHRH-antagonister og mellemprodukterInfo
- Publication number
- DK0668874T3 DK0668874T3 DK92910746T DK92910746T DK0668874T3 DK 0668874 T3 DK0668874 T3 DK 0668874T3 DK 92910746 T DK92910746 T DK 92910746T DK 92910746 T DK92910746 T DK 92910746T DK 0668874 T3 DK0668874 T3 DK 0668874T3
- Authority
- DK
- Denmark
- Prior art keywords
- neu
- pct
- lhrh antagonists
- date
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4117507A DE4117507A1 (de) | 1991-05-24 | 1991-05-24 | Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten |
| PCT/DE1992/000427 WO1992020711A2 (fr) | 1991-05-24 | 1992-05-22 | Antagonistes de la lhrh et produits intermediaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0668874T3 true DK0668874T3 (da) | 1999-05-25 |
Family
ID=6432667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92910746T DK0668874T3 (da) | 1991-05-24 | 1992-05-22 | LHRH-antagonister og mellemprodukter |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5527777A (fr) |
| EP (1) | EP0668874B1 (fr) |
| JP (1) | JP3370668B2 (fr) |
| AT (1) | ATE170190T1 (fr) |
| AU (1) | AU667038B2 (fr) |
| CA (1) | CA2109830C (fr) |
| DE (3) | DE4117507A1 (fr) |
| DK (1) | DK0668874T3 (fr) |
| ES (1) | ES2123554T3 (fr) |
| FI (2) | FI105817B (fr) |
| HU (1) | HU219912B (fr) |
| NO (1) | NO311725B1 (fr) |
| RU (1) | RU2124023C1 (fr) |
| WO (1) | WO1992020711A2 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
| US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
| US5916582A (en) * | 1996-07-03 | 1999-06-29 | Alza Corporation | Aqueous formulations of peptides |
| US5932547A (en) * | 1996-07-03 | 1999-08-03 | Alza Corporation | Non-aqueous polar aprotic peptide formulations |
| US5981489A (en) * | 1996-07-18 | 1999-11-09 | Alza Corporation | Non-aqueous protic peptide formulations |
| US6455499B1 (en) | 1999-02-23 | 2002-09-24 | Indiana University Foundation | Methods for treating disorders associated with LHRH activity |
| DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
| GB201009603D0 (en) * | 2010-06-08 | 2010-07-21 | Cambridge Entpr Ltd | Anti-inflammatory agent |
| AR122446A1 (es) * | 2020-04-29 | 2022-09-14 | Medimmune Llc | Composiciones y métodos para suministrar agentes farmacéuticamente activos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4667014A (en) * | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
| US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
| US4935491A (en) * | 1987-08-24 | 1990-06-19 | Board Of Regents, The University Of Texas System | Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
| IE902446A1 (en) * | 1989-07-26 | 1991-02-13 | Abbott Lab | Peptidyl aminodiol renin inhibitors |
-
1991
- 1991-05-24 DE DE4117507A patent/DE4117507A1/de not_active Withdrawn
-
1992
- 1992-05-22 CA CA002109830A patent/CA2109830C/fr not_active Expired - Fee Related
- 1992-05-22 WO PCT/DE1992/000427 patent/WO1992020711A2/fr active IP Right Grant
- 1992-05-22 RU RU93058365A patent/RU2124023C1/ru not_active IP Right Cessation
- 1992-05-22 US US08/142,429 patent/US5527777A/en not_active Expired - Fee Related
- 1992-05-22 AT AT92910746T patent/ATE170190T1/de not_active IP Right Cessation
- 1992-05-22 DK DK92910746T patent/DK0668874T3/da active
- 1992-05-22 EP EP92910746A patent/EP0668874B1/fr not_active Expired - Lifetime
- 1992-05-22 DE DEDE9200427T patent/DE4291426D2/de not_active Expired - Lifetime
- 1992-05-22 JP JP50975692A patent/JP3370668B2/ja not_active Expired - Fee Related
- 1992-05-22 ES ES92910746T patent/ES2123554T3/es not_active Expired - Lifetime
- 1992-05-22 AU AU18879/92A patent/AU667038B2/en not_active Ceased
- 1992-05-22 DE DE59209476T patent/DE59209476D1/de not_active Expired - Lifetime
- 1992-05-22 HU HU9303324A patent/HU219912B/hu not_active IP Right Cessation
-
1993
- 1993-11-23 FI FI935191A patent/FI105817B/fi not_active IP Right Cessation
- 1993-11-23 NO NO19934237A patent/NO311725B1/no unknown
-
1999
- 1999-06-24 FI FI991441A patent/FI114026B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HU9303324D0 (en) | 1994-03-28 |
| FI105817B (fi) | 2000-10-13 |
| FI935191A0 (fi) | 1993-11-23 |
| JPH06508115A (ja) | 1994-09-14 |
| US5527777A (en) | 1996-06-18 |
| CA2109830A1 (fr) | 1992-11-26 |
| JP3370668B2 (ja) | 2003-01-27 |
| ATE170190T1 (de) | 1998-09-15 |
| CA2109830C (fr) | 2003-04-08 |
| EP0668874B1 (fr) | 1998-08-26 |
| EP0668874A1 (fr) | 1995-08-30 |
| NO934237D0 (no) | 1993-11-23 |
| FI991441A0 (fi) | 1999-06-24 |
| DE59209476D1 (de) | 1998-10-01 |
| AU1887992A (en) | 1992-12-30 |
| DE4291426D2 (de) | 1994-02-17 |
| WO1992020711A3 (fr) | 1993-03-18 |
| ES2123554T3 (es) | 1999-01-16 |
| RU2124023C1 (ru) | 1998-12-27 |
| WO1992020711A2 (fr) | 1992-11-26 |
| HU219912B (hu) | 2001-09-28 |
| FI935191A (fi) | 1993-11-23 |
| HUT65732A (en) | 1994-07-28 |
| NO934237L (no) | 1993-11-23 |
| AU667038B2 (en) | 1996-03-07 |
| FI114026B (fi) | 2004-07-30 |
| FI991441A (fi) | 1999-06-24 |
| NO311725B1 (no) | 2002-01-14 |
| DE4117507A1 (de) | 1992-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9514473D0 (en) | Chemical compounds | |
| GT199800126A (es) | Terapia de combinacion. | |
| ES2124479T3 (es) | Composiciones biocidas. | |
| ES2136723T3 (es) | Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante. | |
| FR2683413B1 (fr) | Un annuleur d'echo. | |
| ES2131528T3 (es) | Nuevos polipeptidos y su uso. | |
| DK0668874T3 (da) | LHRH-antagonister og mellemprodukter | |
| DE69006214D1 (de) | Gesteuerte zerstreuung des eingespritzten brennstoffes. | |
| SE9402880D0 (sv) | New peptide derivatives | |
| PL324690A1 (en) | Improved therapeutic agents | |
| RU93058365A (ru) | Пептидные соединения и содержащее их лекарственное средство | |
| ZA852495B (en) | Anticonvulsant agents | |
| IT8421342A0 (it) | Composizioni e composti per il trattamento dell'adenoma prostatico. | |
| PT100001A (pt) | Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos | |
| JPS52151175A (en) | Gamma-pyrone and gamma-pyridone derivatives | |
| FR2716978B1 (fr) | Dispositif d'observation par émission et réception d'un rayonnement. | |
| Choe et al. | American Society of Zoologists Annual Meeting (December 26-30, 1995) | |
| GR1001368B (el) | Φαρμακευτικοί φορείς. | |
| Go et al. | Internal Structure of Spandex Fibers I-Segmental Orientation | |
| Lee | Development of design management system | |
| IT219198Z2 (it) | Dispositivo di raccordo perfezionato per l'alimentazione di un iniettore. | |
| ES8606298A1 (es) | 1.4-dihidropirazinas | |
| IT8984107A0 (it) | Apparecchiatura per l'identificazione di monete, gettoni e simili, particolarmente per impiego telefonico. | |
| ITRM940025A0 (it) | Valvola dell'iniettore. | |
| NZ510253A (en) | Neuroprotection |